CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Rua Bioscience Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Rua Bioscience Ltd
1 Commerce Place, Awapuni
Phone: +64 63906938p:+64 63906938 GISBORNE, GIS  4071  New Zealand Ticker: RUARUA
Business Summary
Rua Bioscience Limited is a New Zealand-based medicinal cannabis company. The Company is engaged in the business of research and development, and pharmaceutical distribution and marketing. The Company is focused on breeding, cultivating, manufacturing, and supplying medicinal cannabis. The Company operates through one segment: research and development and the sale of pharmaceutical products in Germany and New Zealand. The Company supplies Good Manufacturing Practice (GMP)-certified medicines to expanding markets, supported by international supply agreements in Europe and an Australian partnership for GMP-certified products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20246/30/2024Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board AnnaStove 5/1/2023 5/1/2019
Chief Executive Officer, Interim Managing Director Paul B.Naske 3/1/2023 1/1/2019
Kaihautu Innovation & Regulation ManuCaddie
4 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 286,507,958 (As of 11/12/2024)
Stock Exchange: NZE


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024